Laurus Labs FY26 Net Profit Surges 148% YoY

Laurus Labs reported FY26 revenue of ₹6,813 crore, up 23% YoY, driven by strong growth in its CDMO and Generics divisions.
Net profit surged 148% to ₹889 crore with EBITDA margins expanding 670 bps to 26.8% due to favorable product mix and operational leverage.
The company announced a ₹3,000 crore capex plan and a new 532-acre Vizag site as part of an 8-year, >$600 million investment commitment.
CDMO revenue grew 36% to ₹2,080 crore, while Generics revenue increased 18% to ₹4,733 crore, demonstrating continued business diversification.